Dr. Raizer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 N Saint Clair St
Chicago, IL 60611Phone+1 312-695-0990Fax+1 312-695-1435
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 1996 - 1998
- Yale-New Haven Medical CenterResidency, Neurology, 1993 - 1996
- NYU Grossman School of MedicineResidency, Internal Medicine, 1991 - 1993
- New York Medical CollegeClass of 1991
Certifications & Licensure
- IL State Medical License 2003 - 2026
- NY State Medical License 1996 - 2021
- CT State Medical License 1993 - 1996
- American Board of Psychiatry and Neurology Neurology
- UCNSNeuro-Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Super Doctor SuperDoctors.com
Clinical Trials
- Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma Start of enrollment: 1999 Dec 01
- Taurolidine in Treating Patients With Recurrent or Progressive Glioma Start of enrollment: 2001 May 01
- Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery Start of enrollment: 2005 May 01
- Join now to see all
Publications & Presentations
PubMed
- 562 citationsNovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modalityRoger Stupp, Eric T. Wong, Andrew A. Kanner, David M. Steinberg, Herbert H. Engelhard
European Journal of Cancer. 2012-09-01 - 199 citationsLeptomeningeal metastases: a RANO proposal for response criteria.Marc C. Chamberlain, Larry Junck, Dieta Brandsma, Riccardo Soffietti, Roberta Rudà
Neuro-Oncology. 2014-09-01 - 53 citationsCODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design.Kurt A. Jaeckle, Karla V. Ballman, Martin J. van den Bent, Caterina Giannini, Evanthia Galanis
Neuro-Oncology. 2021-03-25
Press Mentions
- Malnati Brain Tumor Institute Celebrates 10-Year Anniversary at Annual Minds Matter Benefit DinnerMarch 28th, 2018
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: